Dirk Haussecker
My blogs
| Introduction | Services provided: • Scientific due diligence on RNAi trigger designs and delivery technologies, both synthetic and DNA-directed; • Scientific due diligence on microRNA agonist/antagonist designs and delivery, both synthetic and DNA-directed; • Competitive analysis of RNAi-related technologies and companies in the space; • Formulating RNAi Therapeutics business development strategies; • RNAi-related scientific writing targeted at investors; • Reports from scientific conferences. Who might benefit: -RNAi Therapeutics companies; - biotech/pharma companies interested in entering RNAi Therapeutics development; -investors in RNAi-related opportunities. Please send enquiries to: dirk (dot) haussecker (at) gmail (dot) com About Me: Until 2009 a post-doc at Stanford University, I have been involved in RNAi-related research for over 9 years and am excited about the therapeutic prospects of this technology. I currently work as a freelance RNAi Therapeutics analyst/consultant, based on science, aware of the markets. |
|---|